Gallstone Pancreatitis Clinical Trial
Official title:
Pentoxifylline Treatment in Acute Pancreatitis: A Double-Blind Placebo - Controlled Randomized Trial
The purpose of this study was to determine the effects (good and bad) of giving a drug called pentoxifylline to patients with acute pancreatitis.
Participants were randomized to either the treatment group (Pentoxifylline medication) or the
control group (Placebo).
Participant took a pill orally, starting from the time of admission. Participants received a
total of 9 doses over the three days of hospitalization (72 hours).
Research blood draws were done at baseline and on 5 successive days or until the time of
discharge, whichever occured earlier. The study gathered clinical follow up information up to
4 months following hospitalization regarding the diagnosis of acute pancreatitis.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02461147 -
Prospective Validation of "Cholecystectomy First" Strategy for Gallstone Migration
|
||
| Completed |
NCT00863642 -
Early Versus Delayed Surgery for Gallstone Pancreatitis
|
N/A | |
| Terminated |
NCT02590978 -
Early Cholecystectomy in Patients With Mild Gallstone Acute Pancreatitis
|
N/A | |
| Not yet recruiting |
NCT04922528 -
Visualization of the Extrahepatic biliaRy Tree Trial
|
N/A |